Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging

American Journal of Surgery

Volumn 198, Issue 4, 2009, Pages 538-543

  Samphao, Srila ^a   Wheeler, Amanda J ^a   Rafferty, Elizabeth ^a   Michaelson, James S ^a   Specht, Michelle C ^a   Gadd, Michele A ^a   Hughes, Kevin S ^a   Smith, Barbara L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast cancer; Digital mammography; Genetic testing; Magnetic resonance imaging; Young women

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST SELF EXAMINATION; CANCER INVASION; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIGITAL MAMMOGRAPHY; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGE FACTORS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENETIC SCREENING; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; TIME FACTORS; YOUNG ADULT;

EID: 70349567238     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.06.010     Document Type: Article

References (34)

1. Bouchardy C., Fioretta G., Verkooijen H.M., et al. Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer 96 (2007) 1743-1746
2. Agarwal G., Pradeep P.V., Aggarwal V., et al. Spectrum of breast cancer in Asian women. World J Surg 31 (2007) 1031-1040
3. Brinton L.A., Sherman M.E., Carreon J.D., et al. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100 (2008) 1643-1648
4. American Cancer Society. Breast cancer facts and figures. http://www.cancer.org/downloads/stt/caff2005brf.pdf Accessed: March 16, 2009
5. Xiong Q., Valero V., Kau V., et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer 92 (2001) 2523-2528
6. Gonzalez-Angulo A.M., Broglio K., Kau S.W., et al. Women age ≤35 years with primary breast carcinoma: disease features at presentation. Cancer 103 (2005) 2466-2472
7. Loman N., Johannsson O., Kristoffersson U., et al. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93 (2001) 1215-1223
8. Mintzer D., Glassburn J., Mason B.A., et al. Breast cancer in the very young patient: a multidisciplinary case presentation. Oncologist 7 (2002) 547-554
9. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353 (2005) 1773-1783
10. Kriege M., Brekelmans C.T., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 (2004) 427-437
11. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 (2005) 8469-8476
12. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicenter cohort study (MARIBS). Lancet 365 (2005) 1769-1778
13. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast cancer screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
14. Samphao S., Wheeler A.J., Rafferty E., et al. Have genetic testing, digital mammography and MRI screening resulted in earlier detection of breast cancer in women under age 40?. (abstract). Am Surg Onc 16 (2009) 56-57
15. Smith R.A., Saslow D., Sawyer K.A., et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 53 (2003) 141-169
16. Smith R.A. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer J Clin 50 (2000) 312-336
17. Kopans D.B. The breast cancer screening controversy: lessons to be learned. J Surg Oncol 67 (1998) 143-150
18. Morrow M., Wong S., and Ventra L. The evaluation of breast masses in women younger than forty years of age. Surgery 124 (1998) 634-640
19. Houssami N., Irwig L., Simpson J.M., et al. Sydney Breast Imaging Accuracy Study. Comparative sensitivity and specificity of mammography and sonography in young women with symptoms. AJR Am J Roentgenol 180 (2003) 935-940
20. Kolb T.M., Lichy J., and Newhouse J.H. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225 (2002) 165-175
21. Michaelson J.S. Mammographic screening: impact on survival. In: Hayat M.A. (Ed). Cancer Imaging (2008), Elsevier, Amsterdam 465-471
22. Michaelson J.S., Satija S., Kopans D., et al. Gauging the impact of breast cancer screening in terms of tumor size and death rate. Cancer 98 (2003) 2114-2124
23. Schnall M.D., Blume J., Bluemke D.A., et al. MRI detection of distinct incidental cancer in women with primary breast cancer studies in IBMC 6883. J Surg Oncol 92 (2005) 32-38
24. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356 (2007) 1295-1303
25. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 183 (2004) 1149-1157
26. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
27. Wooster R., Bignell G., Lancaster J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995) 789-792
28. Couch F.J., DeShano M.L., Blackwood M.A., et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336 (1997) 1409-1415
29. Turchetti D., Cortesi L., Federico M., et al. BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer. Eur J Cancer 36 (2000) 2083-2089
30. Peto J., Collins N., Barfoot R., et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91 (1999) 943-949
31. Robson M., Gilewski T., Haas B., et al. BRCA-associated breast cancer in young women. J Clin Oncol 16 (1998) 1642-1649
32. Antoniou A., Pharoah P.D., Narod S., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72 (2003) 1117-1130
33. Collaborative group on hormonal factors in breast cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358 (2001) 1389-1399
34. Petrucelli N., Daly M.B., Culver J.O.B., et al. BRCA1 and BRCA2 hereditary breast/ovarian cancer. Gene reviews. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=brca1 Accessed: March 23, 2009